North America Hypertrophic and Keloid Scar Treatment Market Growth and Recent Trends by 2027
North America Hypertrophic and Keloid Scar Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Scar Type (Hypertrophic and Keloid), Product Type (Laser Products, Topical Products, Injectables, Other Products), and End User (Hospitals, Clinics, and Homecare)
- Status : Published
- Report Code : TIPRE00025199
- Category : Life Sciences
- No. of Pages : 89
- Available Report Formats :
- Last update date : October 07, 2021
2020 Market Size
US$ 1,972.60 Mn
Base year value
2027 Forecast
US$ 4,053.90 Mn
Projected by 2027
CAGR 2021-2027
10.8 %
Growth rate
Addressable Market
US$ 21,251.62 Mn
(2021-2027)
The hypertrophic and keloid scar treatment market in North America is expected to grow from US$ 1,972.60 million in 2020 to US$ 4,053.90 million by 2027; it is estimated to grow at a CAGR of 10.8% from 2020 to 2027.
The US, Canada, and Mexico are major economies in North America. Advantages of laser treatment is the major factor driving the growth of the North America hypertrophic and keloid scar treatment market. Technological advancements have led to the successful use of laser—especially 585 nm PDL, Q-switched 532 nm frequency-doubled Nd: YAG, and CO2 lasers, among other types—for treating hypertrophic and keloid scars. The laser treatment helps prevent scar formation after surgery; it reduces pain and itching and allows movement that is otherwise limited by the scar. The treatment is widely employed to treat hypertrophic and keloid scars caused by burns. According to the “Laser Management of Hypertrophic Burn Scars: a Comprehensive Review,” published in January 2020, burn-related injury follows more than 70% of hypertrophic scars. Similarly, according to the World Health Organization (WHO), burn is the major public health problem. Every year, ~265,000 deaths are registered due to scalds, electrical burns, and other burn forms. Moreover, 90% of the burn incidences are reported in low- and middle-income countries. As excessive collagen deposition leads to the generation of hypertrophic scars that lead to raised scars, laser treatment proves to be effective against them. Moreover, due to being a minimally invasive method, it ensures reduced scar thickness, pain, and postoperative recovery period. It also helps prevent the need for surgical excision and improves skin pigmentation, pliability, height, pruritus, texture, and heat sensitivity, among other skin conditions of the affected areas. Moreover, this treatment procedure proves to be cost-effective, especially for those opting for medical tourism. Owing to such advantages, there is high demand for the laser treatment curing hypertrophic and keloid scars, which is further anticipated to drive the market in North America.
North America is witnessing a growing number of COVID-19 cases; for instance, the number of cases increased to 400,549 with 12,857 deaths reported in the US. Additionally, Mexico and Canada cases are also growing. The global impacts of COVID-19 have affected several markets, including the hypertrophic and keloid scar treatment market. Although the healthcare sector has witnessed H1N1, SARS, and additional outbreaks in the last few years, the COVID-19 virus has made the situation more difficult due to its transmission mode. Since the outbreak of COVID-19, North America has been witnessing a growing number of COVID-19 cases. Several measures are being taken to restrain the disease and prevent transmission; nevertheless, the excessive number of COVID-19 cases has resulted in the cancellation of doctor's appointment and decreased demand for elective hypertrophic and keloid scar treatment to the long period of lockdown. In the US, due to the growing number of contaminated patients, healthcare practitioners and leading organizations are distracting the flow of health services from research and development to primary care, which slows down the process of innovation.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
North America Hypertrophic and Keloid Scar Treatment Market Segmentation
North America Hypertrophic and Keloid Scar Treatment Market – By Scar Type
- Hypertrophic
- Keloid
North America Hypertrophic and Keloid Scar Treatment Market – By Product Type
- Injectables
- Topical
- Gels
- Silicone Sheets
- Creams
- Other
- Laser
- CO2
- Pulse-Dyed
- Other
- Other
North America Hypertrophic and Keloid Scar Treatment Market – By End User
- Hospitals
- Clinics
- Homecare
North America Hypertrophic and Keloid Scar Treatment Market, by Country
- US
- Canada
- Mexico
North America Hypertrophic and Keloid Scar Treatment Market-Companies Mentioned
- Alliance Pharma PLC
- HRA Pharma
- Mölnlycke Health Care AB.
- Newmedical Technology Inc.
- Perrigo Company plc
- Rejûvaskin
- Smith & Nephew
- Sonoma Pharmaceuticals, Inc
- Suneva Medical
North America Hypertrophic and Keloid Scar Treatment Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 1,972.60 Million |
| Market Size by 2027 | US$ 4,053.90 Million |
| CAGR (2020 - 2027) | 10.8% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2027 |
| Segments Covered |
By Scar Type
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
- Comprehensive Market Sizing and Forecast Analysis
- Detailed Segmentation Analysis
- In-Depth Market Dynamics Assessment
- Regional and Country-Level Insights
- Competitive Landscape and Company Benchmarking
- Strategic Business Intelligence
Recent Reports
Testimonials
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDs
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future Analytica
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample for